Vietnam Plasma Fractionation Market Updates 2024 : Market Dynamics, Key Strategies, Segments, and Competitive Scenario
The Vietnam plasma fractionation market is expected to reach $79.03 million by 2027, registering a CAGR of 5.3% from 2020 to 2027.
WILMINGTON, DELAWARE , UNITED STATES, June 26, 2024 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, โVietnam Plasma Fractionation Market1 by Product, Application, and End User: Opportunity Analysis and Industry Forecast, 2020โ2027."
The Vietnam plasma fractionation market was valued at $56.62 million in 2019, and is expected to reach $79.03 million by 2027, registering a CAGR of 5.3% from 2020 to 2027.
The aging population and pre-existing medical issues among Vietnamese people as a result of the Second Indochina War are expected to fuel the market's expansion for Vietnam plasma fractionation. Furthermore, it is anticipated that the lack of alternatives to plasma fractionated products will propel market expansion in Vietnam, as these products are indestructible due to their histocompatibility, post-translational modifications, and lack of recombinant methods for protein replication. On the other hand, stricter laws that require products to meet higher quality standards as well as integrated logistics for locating and gathering blood plasma and ensuring prompt delivery to clinics, hospitals, and pharmacies are expected to impede market expansion.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/A06438
The market for plasma fractionation in Vietnam is divided into segments based on end user, product, and application. The market is divided into four product categories: coagulation factor VIII, coagulation factor IX, immunoglobulins, and albumin. The Vietnam plasma fractionation market is further divided into two segments: intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) under the immunoglobulin sector. The market is divided into critical care, immunology, hematology, neurology, and other categories based on application. The Vietnam plasma fractionation market is divided into two segments based on the end user: clinical research laboratories and hospitals.
๐๐๐ฒ ๐
๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐๐ ๐๐ก๐ ๐๐ญ๐ฎ๐๐ฒ
Based on product, the immunoglobulin segment was the highest contributor in 2019, growing at a CAGR of 5.6% during the forecast period.
Based on application, the neurology segment was the largest contributor in 2019, and is expected to grow at a CAGR of 5.9%.
On the basis of end user, the hospital segment is likely to dominate the Vietnam plasma fractionation market in the forecast year.
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ ๐
๐จ๐ซ ๐๐ญ๐๐ค๐๐ก๐จ๐ฅ๐๐๐ซ๐ฌ
This report provides a detailed quantitative analysis of the current Vietnam plasma fractionation market trends and forecast estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.
An in-depth Vietnam plasma fractionation market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2027, in terms of value.
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
Key market players within the Vietnam plasma fractionation market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market.
๐๐จ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐๐๐จ๐ซ๐ ๐๐ฎ๐ฒ๐ข๐ง๐ - https://www.alliedmarketresearch.com/purchase-enquiry/A06438
Leading market players analyzed in the research includes
Biotest AG
Baxter International Inc.
Getz Healthcare
Bio Products Laboratory Ltd.
Kedrion Biopharma
Grifols SA
Novo Nordisk
Octapharma
Sanquin Blood Supply Foundation
Sanova Healthcare
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐ ๐๐จ๐ฆ๐๐ข๐ง
๐๐ฎ๐ง๐ญ๐ข๐ง๐ ๐ญ๐จ๐งโ๐ฌ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/huntington%E2%80%99s-disease-treatment-market-A17522
๐๐๐ซ๐๐จ๐ฉ๐๐ง๐ข๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ https://www.alliedmarketresearch.com/sarcopenia-treatment-market-A10526
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
1 https://www.alliedmarketresearch.com/vietnam-plasma-fractionation-market-A06438
2 https://www.globenewswire.com/en/news-release/2020/07/06/2058015/0/en/Vietnam-Plasma-Fractionation-Market-to-Reach-79-03-Million-by-2027-AMR.html
3 https://www.alliedmarketresearch.com/cough-syrup-market-A10312